The Role of Botulinum Neurotoxin A in the Conservative Treatment of Fractures: An Experimental Study on Rats

The Role of Botulinum Neurotoxin A in the Conservative Treatment of Fractures: An Experimental Study on Rats

This paper explores the role of botulinum neurotoxin in aiding fracture recovery through temporary muscle paralysis. Specifically, it investigates the effects of botulinum neurotoxin-induced paralysis of the sternocleidomastoid muscle on clavicle fractures in rats. The research aims to assess safety...

Full description

Saved in:

Bibliographic Details
Main Authors:	Themistoklis Vampertzis, Christina Barmpagianni, Chryssa Bekiari, Georgia D. Brellou, Ioannis A. Zervos, Eleftherios Tsiridis, Nikiforos Galanis
Format:	Article
Language:	English
Published:	Wiley 2024-01-01
Series:	The Scientific World Journal
Online Access:	http://dx.doi.org/10.1155/2024/7446251
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Action of Botulinum Toxin A on the Sternocleidomastoid Muscle: An Experimental Study on Rats
by: Themistoklis Vampertzis, et al.
Published: (2022-01-01)

Overview of botulinum neurotoxin-producing clostridia in soils in France
by: Caroline Le Maréchal, et al.
Published: (2025-08-01)

Therapeutic applications of botulinum neurotoxins in head and neck disorders
by: Ahmad Alshadwi, et al.
Published: (2015-01-01)

Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip
by: Domenico Azarnia Tehran, et al.
Published: (2018-05-01)

Microfluidic Nanobiosensor Detection of Botulinum Neurotoxin Serotype A
by: Shruthi Srinivasan, et al.
Published: (2025-08-01)

Vast applications of botulinum neurotoxin in neurology - systematic review
by: Aleksandra Banach, et al.
Published: (2025-06-01)

Production of monoclonal antibodies against botulinum neurotoxin in Nicotiana benthamiana
by: Kornchanok Sangprasat, et al.
Published: (2024-12-01)

Histopathological changes of the buccal mucosa and skin after botulinum neurotoxin intramuscular injection in rats (immunohistochemical study)
by: Gihan S. Hassan, et al.
Published: (2025-02-01)

Development and Functional Characterization of Monoclonal Antibodies for Botulinum Neurotoxin Serotype A
by: Jingmei Kang, et al.
Published: (2025-05-01)

Botulinum neurotoxin and chronic migraine: muscle fiber chemodenervation or nociceptic system modulation?
by: A. R. Artemenko, et al.
Published: (2015-02-01)

Accelerated neuronal cell recovery from Botulinum neurotoxin intoxication by targeted ubiquitination.
by: Chueh-Ling Kuo, et al.
Published: (2011-01-01)

Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E.
by: Sebastian Miethe, et al.
Published: (2015-01-01)

Probing the structure and function of the protease domain of botulinum neurotoxins using single-domain antibodies.
by: Kwok-Ho Lam, et al.
Published: (2022-01-01)

Intramuscular Botulinum Neurotoxin Injections for Infantile Esotropia: A Durban Academic Hospital Review
by: Mohammed Khan, et al.
Published: (2025-02-01)

The Emerging Role of Botulinum Neurotoxin in Psoriasis Management: A Review of Mechanisms, Evidence, and Challenges
by: Ramadan S. Hussein
Published: (2025-03-01)

Incidence of Dysphagia and Comorbidities in Patients with Cervical Dystonia, Analyzed by Botulinum Neurotoxin Treatment Exposure
by: Richard L. Barbano, et al.
Published: (2025-03-01)

Cleavage of SNAP25 and its shorter versions by the protease domain of serotype A botulinum neurotoxin.
by: Rahman M Mizanur, et al.
Published: (2014-01-01)

New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A
by: Marina Vladimirovna Silkina, et al.
Published: (2024-07-01)

Botulinum neurotoxin type-A when utilized in animals with trigeminal sensitization induced a antinociceptive effect
by: Elcio J Piovesan, et al.
Published: (2016-06-01)

Cryo-EM structure of the botulinum neurotoxin A/SV2B complex and its implications for translocation
by: Basavraj Khanppnavar, et al.
Published: (2025-02-01)

Comparison of Two Botulinum Neurotoxin A Injection Patterns with or without the Medial Lower Eyelid in the Treatment of Blepharospasm
by: Hui Yang, et al.
Published: (2016-01-01)

Do female and male patients with cervical dystonia respond differently to long-term botulinum neurotoxin therapy?
by: Harald Hefter, et al.
Published: (2025-06-01)

Botulinum neurotoxin A mutants with enhanced ganglioside binding show improved potency and altered ganglioside selectivity
by: Geoffrey Masuyer, et al.
Published: (2025-06-01)

Botulinum neurotoxin type-A when utilized in animals with trigeminal sensitization induced a antinociceptive effect
by: Elcio J Piovesan, et al.
Published: (2016-06-01)

International Proficiency Test Targeting a Large Panel of Botulinum Neurotoxin Sero- and Subtypes in Different Matrices
by: Christine Rasetti-Escargueil, et al.
Published: (2024-11-01)

Two-component signal transduction system CBO0787/CBO0786 represses transcription from botulinum neurotoxin promoters in Clostridium botulinum ATCC 3502.
by: Zhen Zhang, et al.
Published: (2013-03-01)

Combined treatment with antitoxin and 3,4-diaminopyridine improves survival outcomes after lethal botulinum neurotoxin challenge
by: Sean W. O’Brien, et al.
Published: (2025-07-01)

Design and evaluation of mRNA encoding recombinant neutralizing antibodies for botulinum neurotoxin type B intoxication prophylaxis
by: Gulisaina Qiaerxie, et al.
Published: (2024-12-01)

Complications and Anatomical Considerations in Botulinum Neurotoxin Type A Injections for Upper Face Rejuvenation: A Systematic Review
by: Maria Kąpa, et al.
Published: (2025-03-01)

D12. Beyond Wrinkles: A Systematic Review and Meta-analysis of Off-label Aesthetic Uses of Botulinum Neurotoxin
by: Morvarid Mehdizadeh, BA, et al.
Published: (2025-05-01)

Economic Evaluation of the InTENSE Program of Therapy Alongside Botulinum Neurotoxin a for the Rehabilitation of Chronic Upper Limb Spasticity
by: Rachel Milte, et al.
Published: (2025-07-01)

Development of a Recombinant Fusion Vaccine Candidate Against Lethal <i>Clostridium botulinum</i> Neurotoxin Types A and B
by: Eun-Sun Choi, et al.
Published: (2025-01-01)

Botulinum Neurotoxin A-Induced Muscle Morphology Changes in Children with Cerebral Palsy: A One-Year Follow-Up Study
by: Charlotte Lambrechts, et al.
Published: (2025-06-01)

Diagnostic Nerve Block to Guide Botulinum Neurotoxin Type A Injection for Clonus in Spastic Equinovarus Foot: A Retrospective Study
by: Mirko Filippetti, et al.
Published: (2024-11-01)

Do Diagnostic Nerve Blocks Affect the Starting Dose of Botulinum Neurotoxin Type A for Spasticity? A Case-Control Study
by: Mirko Filippetti, et al.
Published: (2024-09-01)

The Role of a Conserved Arg-Asp Pair in the Structure and Function of Tetanus Neurotoxin
by: Elizabeth A. Wilson, et al.
Published: (2025-05-01)

Single Tri-Epitopic Antibodies (TeAbs) to Botulinum Neurotoxin Serotypes B, E, and F Recapitulate the Full Potency of a Combination of Three Monoclonal Antibodies in Toxin Neutralization
by: Jianlong Lou, et al.
Published: (2025-06-01)

Phosphatase Inhibitors Function as Novel, Broad Spectrum Botulinum Neurotoxin Antagonists in Mouse and Human Embryonic Stem Cell-Derived Motor Neuron-Based Assays.
by: Erkan Kiris, et al.
Published: (2015-01-01)

Consensus on the Cosmetic Use of a Novel Botulinum Neurotoxin Type A Product (NEWLUX<sup>®</sup>) for Facial Expression Muscles: 2024 Guidelines and Discussions by Korean Experts
by: Nark-Kyoung Rho, et al.
Published: (2025-01-01)

Stable Convergent Polyneuronal Innervation and Altered Synapse Elimination in <i>Orbicularis oculi</i> Muscles from Patients with Blepharospasm Responding Poorly to Recurrent Botulinum Type-A Neurotoxin Injections
by: Brigitte Girard, et al.
Published: (2024-11-01)